Hotline:
+ 49 (0) 2204 2918806

Estudios en la categoría V

Artículo 1 hasta 10 de 91

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  1. Precio neto*
    Año
  2. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    Vermillion, Inc. (VRML) - Medical Equipment - Deals and Alliances Profile

    GlobalData
    67 paginás
    Vermillion, Inc. (VRML) is a molecular diagnostics company. The company offers innovative method to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. It operates under one reportable segment, Novel Diagnostic Tests. VRML’s Novel Diagnostic Tests segment develops diagnostic products for the ident
    Englisch | Zukunftsanalyse | Código: 262270
  3. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    Viamet Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    21 Páginas
    Viamet Pharmaceuticals, Inc. (Viamet) is a pharmaceuticals and healthcare company, based in the US. The company discovers, develops drugs in the biotechnology sector. It provides discovery and development of inhibitors through proprietary metal-binding approach, the Metallophile Technology. Viamet provides the development of small molecul
    Englisch | Zukunftsanalyse | Código: 331892
  4. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    ViOptix Inc. - Medical Equipment - Deals and Alliances Profile

    GlobalData
    18 paginás
    ViOptix Inc. (ViOptix) is a medical device company. The company develops diagnostic and monitoring equipment for use in diagnostic imaging, vascular assessment, clinical monitoring, and ischemia evaluation. It undertakes the design, development, manufacture and marketing of non-invasive local tissue oxygen measuring devices. The company's
    Englisch | Zukunftsanalyse | Código: 269790
  5. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    Vanguard Natural Resources, LLC Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013

    GlobalData
    77 Pages
    Vanguard Natural Resources, LLC Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational data, analysis a
    Englisch | Zukunftsanalyse | Código: 136775
  6. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    VCN Biosciences SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    16 Páginas
    VCN Biosciences SL (VCN) is a biotechnology company. The company develops therapeutic approaches for tumors, which lack treatment. Its product is VCN-01. VCN’s product is a tumor-selective replication-competent adenovirus, which expresses PH20 hyaluronidase. VCN-01 product demonstrates toxicology profile of the virus in animal model. Th
    Englisch | Zukunftsanalyse | Código: 331916
  7. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    ValiBIO SA - Medical Equipment - Deals and Alliances Profile

    GlobalData
    16 paginás
    ValiBIO an oncology diagnostics company is jointly supported by ValiRx plc an AIM listed biotechnology company based in London, UK and BIO.be, a Belgian company of the Institut de Pathologie et de Genetique (IPG) which is the largest pathology analysis centre in Belgium. The company is committed to develop a medicine which can provide lon
    Englisch | Zukunftsanalyse | Código: 269879
  8. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    Victoria Oil & Gas plc (VOG) - Oil & Gas - Deals and Alliances Profile

    GlobalData
    38 Pages
    Victoria Oil & Gas plc (Victoria Oil) is an independent oil and gas company. The company acquires, explores and develops oil and gas properties. It has 95% interest in the Logbaba gas and condensate project located in Cameroon; and 100% interest in the West Medvezhye oil and gas project located in Siberia, Russia. Victoria Oil operates th
    Englisch | Zukunftsanalyse | Código: 158752
  9. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    Virdante Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    21 Páginas
    Virdante Pharmaceuticals, Inc. (Virdante) is a privately held biopharmaceutical company engaged in the development and commercialization of drugs for autoimmune and inflammatory disorders. The company uses its proprietary sialic switch technology to develop safer and effective drugs for autoimmune and inflammatory diseases. The company's
    Englisch | Zukunftsanalyse | Código: 338870
  10. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    VirtualScopics, Inc. (VSCP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 Páginas
    VirtualScopics, Inc. (VirtualScopics) is an imaging solutions provider. The company serves pharmaceutical, biotechnology and medical device industries. It has created a group of image analysis software tools and applications to be used to sense and determine precise anatomical structures and metabolic activity using medical images. Virtua
    Englisch | Zukunftsanalyse | Código: 340334
  11. US$ 236,76
    2013
    Für diese Studie liegt keine Bewertung vor.

    ValiRx Plc (VAL) - Medical Equipment - Deals and Alliances Profile

    GlobalData
    21 paginás
    ValiRx Plc (ValiRx) is a biopharmaceutical company, based in the UK. The company develops the novel technologies and products for the treatment of oncology related disorders. Its products include VAL 101 compound that acts to shut down the Bcl-2 gene, a proto-oncogene; and VAL 201, a peptide for the treatment of refractory prostate cancer
    Englisch | SWOT | Código: 298234

Artículo 1 hasta 10 de 91

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10